Clinical trial • Phase III • Haematology
Clinical trial in Acute myeloid leukemia
Phase III trial for Acute myeloid leukemia. 10 participants.
Overview
- Trial Therapeutic Area
- Haematology
- Trial Disease
- Acute myeloid leukemia
- Trial Stage
- Phase III
- Drug Modality
- Cell therapy
Key dates
- Initial CTIS Submission Date
- 30-06-2025
- First CTIS Authorization Date
- 08-09-2025
Trial design
Phase III trial across 5 sites in Germany.
- Target Sample Size
- 10
- Trial Duration For Participant
- 5113
Eligibility
Recruits 10 Vulnerable population selected (isVulnerablePopulationSelected=true). No details on consent or assent provided in the document..
- Vulnerable Population
- Vulnerable population selected (isVulnerablePopulationSelected=true). No details on consent or assent provided in the document.
Recruitment
- Planned Sample Size
- 10
- Recruitment Window Months
- 168
Geography
- Total Number Of Sites
- 5
- Total Number Of Participants
- 10
Germany
- Earliest CTIS Part Ii Submission Date
- 29-07-2025
- Latest Decision Or Authorization Date
- 11-12-2025
- Processing Time Days
- 135
- Number Of Sites
- 5
- Number Of Participants
- 10
Sites
- Site Name
- Technische Universitaet Dresden
- Department Name
- Early Clinical Trial Unit
- Contact Person Name
- Martin Wermke
- Contact Person Email
- Martin.Wermke@uniklinikum-dresden.de
- Site Name
- LMU Klinikum Muenchen AöR
- Department Name
- Medizinische Klinik und Poliklinik III
- Contact Person Name
- Veit Buecklein
- Contact Person Email
- Veit.buecklein@med.uni-muenchen.de
- Site Name
- Charite Universitaetsmedizin Berlin KöR
- Department Name
- Department of Hematology, Oncology and Tumor Immunology
- Contact Person Name
- Jörg Westermann
- Contact Person Email
- joerg.westermann@charite.de
- Site Name
- Universitaetsklinikum Ulm AöR
- Department Name
- Department of Internal Medicine III
- Contact Person Name
- Elisa Sala
- Contact Person Email
- elisa.sala@uniklinik-ulm.de
- Site Name
- Philipps-Universitaet Marburg
- Department Name
- Hematology, Oncology, Immunology
- Contact Person Name
- Stephan Metzelder
- Contact Person Email
- metzelde@med.uni-marburg.de
Sponsor
Primary sponsor
- Full Name
- Avencell Therapeutics Inc.
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- United States
Related trials
Other published trials that may interest you.